Michelle E A Borm

Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial

J. W. J. Bijlsma, Paco M J Welsing, Thasia Woodworth et al. · The Lancet · 2016 · 238 citations

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +8

Evaluation of the International Study Group of Pancreatic Surgery definition of delayed gastric emptying after pancreatoduodenectomy in a high-volume centre

Thilo Welsch, Michelle E A Borm, Luca Degrate et al. · British journal of surgery · 2010 · 149 citations · Full text

A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis

Michelle E A Borm, Adriaan A. van Bodegraven, Chris J. Mulder et al. · International Journal of Immunogenetics · 2005 · 90 citations · Full text

Chronic Inflammatory Diseases, Genetics, Genetic Epidemiology +16

Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors

Xavier M Teitsma, Johannes W. G. Jacobs, Paco M J Welsing et al. · Annals of the Rheumatic Diseases · 2018 · 50 citations

A major quantitative trait locus on mouse chromosome 3 is involved in disease susceptibility in different colitis models

Michelle E A Borm, Jianping He, Brian L. Kelsall et al. · Gastroenterology · 2005 · 46 citations · Full text

Mouse Chromosome 3, Disease Susceptibility, Genetics +9